论文部分内容阅读
目的探讨布地奈德和可必特联合雾化吸入治疗毛细支气管炎临床效果。方法将2010年1月～2011年3月我院收治的96例毛细支气管炎患儿随机分为治疗组48例和对照组48例。两组均常规给予抗病毒、止咳、化痰、平喘等对症支持治疗,治疗组在此基础上加用布地奈德和可必特雾化吸入;对照组予氨茶碱及糖皮质激素静脉用药治疗。结果治疗组治疗后喘憋、咳嗽、肺部啰音消失时间较对照组均减少,两组疗效比较均有显著性差异(P均<0.O1)。结论布地奈德和可必特联合雾化吸入治疗毛细支气管炎疗效显著。
Objective To investigate the clinical effect of budesonide and bebite combined with inhalation on bronchiolitis. Methods From January 2010 to March 2011, 96 children with bronchiolitis admitted to our hospital were randomly divided into treatment group (48 cases) and control group (48 cases). The two groups were routinely given symptomatic and supportive treatment such as antivirus, cough-relieving, phlegm-resolving and antiasthmatic treatment. On the basis of this, the treatment group added budesonide and nocturnarham inhalation; the control group received aminophylline and glucocorticoid vein Medication. Results After treatment, the treatment group had less wheezing, cough and disappearance of pulmonary rales compared with the control group. The curative effect of the two groups were significantly different (all P <0.01). Conclusions Budesonide and Kebite combination inhalation therapy for bronchiolitis have a significant effect.